openPR Logo
Press release

Hypertrophic Cardiomyopathy Treatment Market: Key Drivers, Insights, Outlook, Overview, and Research Report 2024-2033

08-13-2024 06:16 AM CET | Health & Medicine

Press release from: The Business research company

Hypertrophic Cardiomyopathy Treatment Market

Hypertrophic Cardiomyopathy Treatment Market

"The new report published by The Business Research Company, titled Hypertrophic Cardiomyopathy Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the hypertrophic cardiomyopathy treatment market size has grown steadily in recent years. It will grow from $1.31 billion in 2023 to $1.37 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The hypertrophic cardiomyopathy treatment market size is expected to see steady growth in the next few years. It will grow to $1.62 billion in 2028 at a compound annual growth rate (CAGR) of 4.4%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13017&type=smp

Rising Obesity Rates Fuel Growth In Hypertrophic Cardiomyopathy Treatment Market
The increase in obesity is expected to propel the growth of the hypertrophic cardiomyopathy treatment market going forward. Obesity describes an abnormal or excessive fat build up that harms health. Obesity frequently arises from consuming more calories than are burnt through exercise and daily activities. The phenotype of hypertrophic cardiomyopathy (HCM) is thought to be influenced by obesity, which is very frequent in people with HCM. For instance, in March 2022, according to a report published by the World Health Organization, a Switzerland-based organization for public health, obesity affects more than one billion people globally, including 650 million adults, 340 million adolescents and 39 million children. Further, by 2025, roughly 167 million additional individuals will be less healthy due to being overweight or obese. Therefore, the increase in obesity will drive the hypertrophic cardiomyopathy treatment market.

Innovative Drug Development Drives Advancements In Hypertrophic Cardiomyopathy Treatment Market
Companies operating in the hypertrophic cardiomyopathy treatment market are working on new drug development to sustain their position in the market. Drug development and innovation boost scientific insights into disease mechanisms and accelerate the growth of new treatments. For instance, in April 2022, Bristol Myers Squibb Co., a US-based pharmaceutical development and manufacturing company, announced that the US Food and Drug Administration (FDA) had approved Camzyos (mavacamten) to be used in the treatment of people with symptoms of obstructive hypertrophic cardiomyopathy (obstructive HCM), New York Heart Association (NYHA) class II-III. Camzyos is a novel allosteric and reversible cardiac myosin inhibitor that addresses the underlying pathology of obstructive HCM. With this FDA clearance, cardiologists in the United States will now have a new pharmaceutical alternative for eligible patients that tackles the disease's underlying pathophysiology.

The hypertrophic cardiomyopathy treatment market covered in this report is segmented -

1) By Disease Type: Obstructive Hypertrophic Cardiomyopathy Treatment; Non-Obstructive Hypertrophic Cardiomyopathy Treatment
2) By Diagnosis: Chest X-Ray; Echocardiogram; Electrocardiogram (ECG); Treadmill Stress Test; Cardiac Catheterization; Cardiac MRI; Cardiac CT Scan; Blood Tests; Genetic Testing Or Screening
3) By Treatment: Medication; Surgically Implanted Devices; Nonsurgical Procedures; Surgery
4) By End-User: Hospitals; Research Institutes; Specialty Clinics

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13017&type=discount

Major players in the hypertrophic cardiomyopathy treatment market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories Ltd., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Mylan N.V., Sun Pharmaceutical Industries Ltd., PerkinElmer Inc., Cipla Ltd., Aurobindo Pharma Ltd., Bio-Rad Laboratories Inc., Covance Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo International Inc., Lupin Limited, Zydus Lifesciences Limited, XyloCor Therapeutics Inc., Cytokinetics Inc., Santhera Pharmaceuticals Holding AG, DiNAQOR AG, Correvio Pharma Corp, Cardurion Pharmaceuticals Inc.

Contents of the report:
1. Executive Summary
2. Hypertrophic Cardiomyopathy Treatment Market Report Structure
3. Hypertrophic Cardiomyopathy Treatment Market Trends And Strategies
4. Hypertrophic Cardiomyopathy Treatment Market - Macro Economic Scenario
5. Hypertrophic Cardiomyopathy Treatment Market Size And Growth
…..
27. Hypertrophic Cardiomyopathy Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/hypertrophic-cardiomyopathy-treatment-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hypertrophic Cardiomyopathy Treatment Market: Key Drivers, Insights, Outlook, Overview, and Research Report 2024-2033 here

News-ID: 3620629 • Views:

More Releases from The Business research company

Analysis of Segments and Major Growth Areas in the Insurance Brokers and Agents …
The insurance brokers and agents sector is positioned for notable expansion as demand for intermediary services continues to grow. Driven by evolving healthcare challenges and economic shifts in emerging markets, this industry is adapting to new technological trends and strategic partnerships that promise to reshape its landscape in the coming years. Let's explore the market size, key players, emerging trends, and segmentation insights shaping this dynamic field. Strong Market Growth Expected
Emerging Growth Trends Driving Expansion in the RegTech Market
The regulatory technology (RegTech) sector is gaining significant traction as organizations seek more efficient ways to manage compliance and regulatory challenges. With digital transformation accelerating across industries, RegTech is positioned to play a pivotal role over the coming years. Let's explore the market's projected growth, key players, emerging trends, and vital segments shaping this dynamic industry. Projected Expansion and Size of the RegTech Market The RegTech market is set to
Segmentation Analysis, Market Trends, and Competitive Landscape in the Insurance …
The insurance sector is poised for substantial growth over the coming years, driven by technological innovations and evolving risk landscapes. As digital transformation reshapes how insurance services are delivered, the industry is adapting to new challenges and opportunities that promise to redefine its future. Let's explore the market's growth projections, key players, emerging trends, and detailed segmentation. Projected Expansion and Market Size of the Insurance Industry The insurance market is
Analysis of Segments and Major Growth Areas in the Money Transfer Services Marke …
The money transfer services sector is rapidly evolving, driven by technological advancements and changing consumer expectations. As global financial connectivity deepens, businesses and individuals alike are seeking faster, safer, and more convenient ways to send and receive money. This overview explores the market's size, key players, emerging trends, and segment dynamics shaping its future trajectory. Projected Growth and Market Size of the Money Transfer Services Market The money transfer services

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any